News from inovio pharmaceuticals inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 15, 2014, 08:59 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange

 Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has met the stringent listing criteria for the NASDAQ Global Select Market...

Sep 04, 2014, 09:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals to List on NASDAQ

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it has met the listing criteria for the NASDAQ Global Select Market and will...

Sep 03, 2014, 08:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio to Present at Upcoming Investor Conferences

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Inovio will present at the upcoming Rodman and Renshaw Investment Conference in...

Aug 11, 2014, 08:30 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million...

Aug 01, 2014, 08:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call to report its second quarter 2014 financial...

Jul 23, 2014, 09:15 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced successful results from its randomized, double-blind, placebo-controlled phase II...

Jul 01, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced that it has been added to the Russell Global, Russell 2000 and Russell Microcap...

Jun 23, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Initiates Cervical Cancer Clinical Trial

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity,...

Jun 17, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Broadens its Intellectual Property Portfolio from the University of Pennsylvania

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has expanded its existing license agreement with the University of Pennsylvania, adding exclusive...

Jun 16, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals to Present at Upcoming Healthcare Conferences

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President & CEO, Dr. J. Joseph Kim, will participate in a panel at the Piper...

Jun 11, 2014, 09:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Clarifies Facts of its VGX-3100 Phase II Trial and Immunotherapy Technology

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) wishes to clarify that a third party article published on June 10, 2014, was misrepresentative of...

Jun 10, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Initiates Immune Therapy Trial for Head & Neck Cancer Caused by HPV

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a...

May 30, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Announces Reverse Stock Split Date

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its previously announced 1-for-4 reverse stock split shall become effective...

May 27, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Breakthrough DNA-Based Monoclonal Antibody Therapy Completely Protects Animals From Lethal Viral Challenge

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its novel DNA-based therapeutic monoclonal antibody targeting Chikungunya...

May 27, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Subsidiary Sells Animal Health Assets

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its 90%-owned subsidiary, VGX Animal Health, Inc. (VAH), has concluded an...

May 23, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Announces 1 For 4 Reverse Split

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that at the Company's Annual General Meeting held May 22, 2014, the Company's...

May 21, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. Joseph Kim, President and CEO, will give a corporate presentation at the...

May 13, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today it acquired worldwide rights (excluding China) for early preclinical therapies...

May 12, 2014, 06:10 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals Reports 2014 First Quarter Financial Results

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended March 31,...

May 05, 2014, 04:00 ET
Inovio Pharmaceuticals.  (PRNewsFoto/Inovio Pharmaceuticals, Inc.)

Inovio Pharmaceuticals to Report First Quarter 2014 Financial Results on May 12, 2014

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its first quarter...